IPV Leads Iom Bioworks ₹4 Cr in Seed Round to Revolutionize Healthcare Through Gut Microbiome Science
Iom Bioworks is dedicated to using the gut microbiome's power to revolutionize contemporary healthcare.
The funds will be used to boost customer outreach, secure IP rights, scale infrastructure, and grow the core team.
In its first year, Iom Bioworks reached 500 users, secured two patents globally (with two more underway), and published multiple papers in the microbiome and computational biology space.
So far, Inflection Point Ventures has invested over INR 800 Cr across 210+ startups.
L-R, Samik Ghosh, Co-Founder & Chief of Science & Technology, Dr. Hiroaki Kitano, Co-Founder & Chief of Research & Collaboration, Bipin Pradeep Kumar, Co-Founder and CEO_Iom Bioworks
EO brings strategic vision and collaborative approach to leadership, integrating microbiome research with technology, artificial intelligence and customer focus. Dr. Samik Ghosh, Co-Founder & Chief of Science & Technology, uses his expertise at the intersection of computation and biology to develop innovative microbiome-driven health and wellness solutions that drive sustainable health for life of people and the planet. Dr. Hiroaki Kitano, Co-Founder & Chief of Research & Collaboration, a world-renowned systems biologist and AI specialist brings decades of leadership in robotics, systems biology, and AI-driven scientific discovery to create innovative collaborations.
“Lifestyle diseases have been on the rise due to multiple reasons like poor diet, stress, lack of sleep and are intimately linked to poor gut health and microbial composition. The gut microbiome plays a huge role in your digestion, immunity, metabolism, and even mood. Understanding it can help prevent a myriad of these diseases and also provide a better quality of life. Iom Bioworks is making this cutting-edge science accessible, personalised and importantly, actionable. With their vision and science, they make a compelling bet in preventive and therapeutic healthcare”, says Vinay Bansal, Founder, IPV.
“Iom Bioworks envisions a world where a healthy mind and body are achievable through informed choices that nurture the microbiome. By empowering our inner ecosystem through prebiotics and a food and lifestyle centred around the bacteria, we aim to energize daily life while preserving the joy of living. Partnering with IPV has been transformative; their supportive and diligent approach has set us firmly on the path toward this vision”, says Bipin Pradeep Kumar.
At a compound annual growth rate (CAGR) of 28%, the worldwide market for health tests, subscriptions, and wellness platforms is expected to reach USD 900 billion by 2030. Iom Bioworks is well positioned to lead this transformation to personalised accessible gut health with its scalable approach, user focus and the foundation of deep science and research.
Got a story that Healthcare Executive should dig into? Shoot it over to arunima.rajan@hosmac.com—no PR fluff, just solid leads.